Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jan;35(1):48–52. doi: 10.1128/jcm.35.1.48-52.1997

Rabbit model for Chlamydia pneumoniae infection.

I W Fong 1, B Chiu 1, E Viira 1, M W Fong 1, D Jang 1, J Mahony 1
PMCID: PMC229510  PMID: 8968879

Abstract

A rabbit model was established for Chlamydia pneumoniae infection that may be helpful to understand the pathogenesis of disease in humans. Twelve, pathogen-free, 1-month-old New Zealand White rabbits were inoculated with 1.0 x 10(7) to 5.0 x 10(7) CFU of purified C. pneumoniae (ATCC strain VR 1310) via the nasopharynx (1 rabbit died immediately postinoculation, and 11 were available for study). Five controls were inoculated with the carrier buffer. Ten of the 11 study rabbits demonstrated serological evidence of acute infection (immunoglobulin G antibodies, 1:8 to > 1:16), with the weakest response at 7 days and the strongest response at 28 days, whereas none of the controls showed any seroconversion. Study animals were sacrificed in batches of three, on days 7, 14, 21, and 28, but controls were sacrificed on days 7 and 28. Two-thirds of the animals demonstrated evidence of bronchiolitis and pneumonia on days 7 and 14 and resolution by day 21. Two study rabbits demonstrated, on histology, early and intermediate lesions of atherosclerosis: one animal (day 7) showed the accumulation of foamy macrophages (fatty streak) in the arch of the aorta, and the other animal (day 14) showed spindle cell proliferation of smooth muscle cells (intermediate lesion). Focal periaortitis was seen in the same animal (day 7). C. pneumoniae elementary bodies were demonstrated by immunocytochemical stain in the lungs (n = 2), liver (n = 3), spleen (n = 5), and aorta (n = 2), one of which corresponded to the intermediate lesion. C. pneumoniae was cultured from the lungs (n = 2), liver (n = 2), spleen (n = 2), and aortic arch (n = 1). All histopathological, immunocytochemical, and cultural studies were negative in the controls. Hence, the rabbit provides a useful animal model for the study of C. pneumoniae infection and its complications, particularly atherosclerosis.

Full Text

The Full Text of this article is available as a PDF (477.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell T. A., Kuo C. C., Wang S. P., Grayston J. T. Experimental infection of baboons (Papio cynocephalus anubis) with Chlamydia pneumoniae strain 'TWAR'. J Infect. 1989 Jul;19(1):47–49. doi: 10.1016/s0163-4453(89)94850-0. [DOI] [PubMed] [Google Scholar]
  2. Campbell L. A., O'Brien E. R., Cappuccio A. L., Kuo C. C., Wang S. P., Stewart D., Patton D. L., Cummings P. K., Grayston J. T. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995 Aug;172(2):585–588. doi: 10.1093/infdis/172.2.585. [DOI] [PubMed] [Google Scholar]
  3. Dahlén G. H., Boman J., Birgander L. S., Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis. 1995 Apr 24;114(2):165–174. doi: 10.1016/0021-9150(94)05480-7. [DOI] [PubMed] [Google Scholar]
  4. Daley S. J., Klemp K. F., Guyton J. R., Rogers K. A. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arterioscler Thromb. 1994 Jan;14(1):105–141. doi: 10.1161/01.atv.14.1.105. [DOI] [PubMed] [Google Scholar]
  5. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  6. Holland S. M., Taylor H. R., Gaydos C. A., Kappus E. W., Quinn T. C. Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun. 1990 Mar;58(3):593–597. doi: 10.1128/iai.58.3.593-597.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaukoranta-Tolvanen S. E., Laurila A. L., Saikku P., Leinonen M., Laitinen K. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Microb Pathog. 1995 Apr;18(4):279–288. doi: 10.1016/s0882-4010(05)80004-x. [DOI] [PubMed] [Google Scholar]
  8. Kuo C. C., Chen H. H., Wang S. P., Grayston J. T. Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol. 1986 Dec;24(6):1034–1037. doi: 10.1128/jcm.24.6.1034-1037.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuo C. C., Gown A. M., Benditt E. P., Grayston J. T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993 Oct;13(10):1501–1504. doi: 10.1161/01.atv.13.10.1501. [DOI] [PubMed] [Google Scholar]
  10. Kuo C. C., Grayston J. T. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Sep;162(3):755–758. doi: 10.1093/infdis/162.3.755. [DOI] [PubMed] [Google Scholar]
  11. Kuo C. C., Shor A., Campbell L. A., Fukushi H., Patton D. L., Grayston J. T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993 Apr;167(4):841–849. doi: 10.1093/infdis/167.4.841. [DOI] [PubMed] [Google Scholar]
  12. Linnanmäki E., Leinonen M., Mattila K., Nieminen M. S., Valtonen V., Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993 Apr;87(4):1130–1134. doi: 10.1161/01.cir.87.4.1130. [DOI] [PubMed] [Google Scholar]
  13. Marrie T. J. Community-acquired pneumonia. Clin Infect Dis. 1994 Apr;18(4):501–515. doi: 10.1093/clinids/18.4.501. [DOI] [PubMed] [Google Scholar]
  14. Melnick S. L., Shahar E., Folsom A. R., Grayston J. T., Sorlie P. D., Wang S. P., Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med. 1993 Nov;95(5):499–504. doi: 10.1016/0002-9343(93)90332-j. [DOI] [PubMed] [Google Scholar]
  15. Mendall M. A., Carrington D., Strachan D., Patel P., Molineaux N., Levi J., Toosey T., Camm A. J., Northfield T. C. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995 Mar;30(2):121–128. doi: 10.1016/s0163-4453(95)80006-9. [DOI] [PubMed] [Google Scholar]
  16. Moazed T. C., Kuo C., Patton D. L., Grayston J. T., Campbell L. A. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol. 1996 Feb;148(2):667–676. [PMC free article] [PubMed] [Google Scholar]
  17. Patel P., Mendall M. A., Carrington D., Strachan D. P., Leatham E., Molineaux N., Levy J., Blakeston C., Seymour C. A., Camm A. J. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995 Sep 16;311(7007):711–714. doi: 10.1136/bmj.311.7007.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Richardson M., Kurowska E. M., Carroll K. K. Early lesion development in the aortas of rabbits fed low-fat, cholesterol-free, semipurified casein diet. Atherosclerosis. 1994 Jun;107(2):165–178. doi: 10.1016/0021-9150(94)90018-3. [DOI] [PubMed] [Google Scholar]
  19. Saikku P., Leinonen M., Mattila K., Ekman M. R., Nieminen M. S., Mäkelä P. H., Huttunen J. K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988 Oct 29;2(8618):983–986. doi: 10.1016/s0140-6736(88)90741-6. [DOI] [PubMed] [Google Scholar]
  20. Saikku P., Leinonen M., Tenkanen L., Linnanmäki E., Ekman M. R., Manninen V., Mänttäri M., Frick M. H., Huttunen J. K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992 Feb 15;116(4):273–278. doi: 10.7326/0003-4819-116-4-273. [DOI] [PubMed] [Google Scholar]
  21. Shor A., Kuo C. C., Patton D. L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992 Sep;82(3):158–161. [PubMed] [Google Scholar]
  22. Thom D. H., Grayston J. T., Siscovick D. S., Wang S. P., Weiss N. S., Daling J. R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992 Jul 1;268(1):68–72. [PubMed] [Google Scholar]
  23. Thom D. H., Wang S. P., Grayston J. T., Siscovick D. S., Stewart D. K., Kronmal R. A., Weiss N. S. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 1991 May-Jun;11(3):547–551. doi: 10.1161/01.atv.11.3.547. [DOI] [PubMed] [Google Scholar]
  24. Yang Z. P., Cummings P. K., Patton D. L., Kuo C. C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis. 1994 Aug;170(2):464–467. doi: 10.1093/infdis/170.2.464. [DOI] [PubMed] [Google Scholar]
  25. Yang Z. P., Kuo C. C., Grayston J. T. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun. 1993 May;61(5):2037–2040. doi: 10.1128/iai.61.5.2037-2040.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yang Z. P., Kuo C. C., Grayston J. T. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis. 1995 Mar;171(3):736–738. doi: 10.1093/infdis/171.3.736. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES